DBV TECHNOLOGIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.186 EUR | -1.17% |
|
-4.35% | -35.86% |
Presentation Operator MessageOperator (Operator)Hello, everybody. Our presentation will be sta...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Sector
Pharmaceuticals
Calendar
2024-05-01
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.186
EUR
Average target price
4.783
EUR
Spread / Average Target
+303.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -35.86% | 122M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
- Stock Market
- Equities
- DBV Stock
- News DBV Technologies
- Transcript : DBV Technologies S.A., 2023 Earnings Call, Mar 07, 2024
